Translation, cultural adaptation, and psychometric evaluation of the Thai version of the drooling severity and frequency scale for assessing clozapine-induced hypersalivation

Objectives Clozapine-induced hypersalivation is a common adverse effect that may negatively affect treatment adherence, quality of life, and patient satisfaction. This study aimed to translate the Drooling Severity and Frequency Scale (DSFS) into Thai and evaluate its validity and reliability among patients with psychiatric disorders receiving clozapine. Methods A cross-sectional psychometric evaluation study was conducted following established translation and cultural adaptation procedures. The original English version of the DSFS was independently translated into Thai by two bilingual translators, followed by back-translation by an independent translator. Two experts evaluated semantic equivalence between the versions. The reconciled Thai version underwent content validation by six psychiatric healthcare professionals. Face validity was assessed through cognitive interviews with 10 patients receiving clozapine. The association between the severity and frequency items was assessed using inter-item correlation, while 14-day test-retest agreement was evaluated using linear weighted Cohen’s kappa for the individual items and the intraclass correlation coefficient (ICC) for the total score. Results Fifty clozapine-treated psychiatric outpatients participated in the reliability assessment (mean age 43.8 ± 13.6 years; 72% male). The mean clozapine dose was 122.8 ± 137.4 mg/day. The Thai DSFS required approximately 1–2 minutes to complete. Content validity was excellent, with item-level and scale-level content validity indices of 1.00. Cognitive interviews indicated that the instrument was generally comprehensible and acceptable to participants. The severity and frequency items were strongly correlated ( r = 0.783). Test-retest agreement was strong for the individual items, with linear weighted kappa values of 0.823 (95% CI, 0.670-0.976) for severity and 0.829 (95% CI, 0.692-0.966) for frequency, while the total-score ICC was 0.826 (95% CI, 0.712-0.898), indicating good test-retest reliability. However, reliability estimates were lower in the subgroup of participants with hypersalivation at baseline. Conclusions The Thai version of the DSFS demonstrated satisfactory content validity, comprehensibility, a strong inter-item correlation, and good test-retest reliability in the overall sample of patients receiving clozapine. These findings provide preliminary support for its potential use as a brief and practical measure of drooling severity and frequency in Thai clinical and research settings. Further evaluation of additional measurement properties and performance across the full spectrum of clozapine-induced hypersalivation severity is needed.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2026-11-16
DOI
https://doi.org/10.3389/fpsyt.2026.1970383
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Translation, cultural adaptation, and psychometric evaluation of the Thai version of the drooling severity and frequency scale for assessing clozapine-induced hypersalivation

Siripan Phattanarudee, Tatta Sriboonruang, Pojanard Sernsooksumrith, Yen-Ming Huang et al.
Frontiers in Psychiatry
Schizophrenia research and treatment
article

Translation, cultural adaptation, and psychometric evaluation of the Thai version of the drooling severity and frequency scale for assessing clozapine-induced hypersalivation

Siripan Phattanarudee, Tatta Sriboonruang, Pojanard Sernsooksumrith, Yen-Ming Huang, Suparat Seneesrisakul
article en

Abstract

Objectives Clozapine-induced hypersalivation is a common adverse effect that may negatively affect treatment adherence, quality of life, and patient satisfaction. This study aimed to translate the Drooling Severity and Frequency Scale (DSFS) into Thai and evaluate its validity and reliability among patients with psychiatric disorders receiving clozapine. Methods A cross-sectional psychometric evaluation study was conducted following established translation and cultural adaptation procedures. The original English version of the DSFS was independently translated into Thai by two bilingual translators, followed by back-translation by an independent translator. Two experts evaluated semantic equivalence between the versions. The reconciled Thai version underwent content validation by six psychiatric healthcare professionals. Face validity was assessed through cognitive interviews with 10 patients receiving clozapine. The association between the severity and frequency items was assessed using inter-item correlation, while 14-day test-retest agreement was evaluated using linear weighted Cohen’s kappa for the individual items and the intraclass correlation coefficient (ICC) for the total score. Results Fifty clozapine-treated psychiatric outpatients participated in the reliability assessment (mean age 43.8 ± 13.6 years; 72% male). The mean clozapine dose was 122.8 ± 137.4 mg/day. The Thai DSFS required approximately 1–2 minutes to complete. Content validity was excellent, with item-level and scale-level content validity indices of 1.00. Cognitive interviews indicated that the instrument was generally comprehensible and acceptable to participants. The severity and frequency items were strongly correlated ( r = 0.783). Test-retest agreement was strong for the individual items, with linear weighted kappa values of 0.823 (95% CI, 0.670-0.976) for severity and 0.829 (95% CI, 0.692-0.966) for frequency, while the total-score ICC was 0.826 (95% CI, 0.712-0.898), indicating good test-retest reliability. However, reliability estimates were lower in the subgroup of participants with hypersalivation at baseline. Conclusions The Thai version of the DSFS demonstrated satisfactory content validity, comprehensibility, a strong inter-item correlation, and good test-retest reliability in the overall sample of patients receiving clozapine. These findings provide preliminary support for its potential use as a brief and practical measure of drooling severity and frequency in Thai clinical and research settings. Further evaluation of additional measurement properties and performance across the full spectrum of clozapine-induced hypersalivation severity is needed.

Frontiers in PsychiatryVol. 17
Chulalongkorn University (TH), National Taiwan University (TW), National Taiwan University Hospital (TW), Buddhasothorn Hospital (TH)
Good health and well-being
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon